You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carboplatin

Showing 1 - 25 of 1,824
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Shreveport, Louisiana
  • +3 more
Oct 3, 2023

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023

Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)

Not yet recruiting
  • Prostate Cancer
  • ADI-PEG 20
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 16, 2023

Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023

Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)

Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Carboplatin
  • Groningen, Netherlands
  • +3 more
Jan 27, 2023

Ovarian Cancer Trial in San Diego (VS-6063, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • San Diego, California
    University of California San Diego
Feb 1, 2023

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom

Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +3 more
Dec 19, 2022

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Carmel, Indiana
  • +2 more
Apr 27, 2023

Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)

Active, not recruiting
  • Adult Solid Neoplasm
  • Carboplatin
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 25, 2023

Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)

Active, not recruiting
  • Lung Cancer
  • Carboplatin
  • +2 more
  • Tampa, Florida
  • +1 more
Feb 2, 2023

Lung Cancer Trial in Carlsbad, Cleveland (ISIS 3521, carboplatin, paclitaxel)

Completed
  • Lung Cancer
  • ISIS 3521
  • +2 more
  • Carlsbad, California
  • +1 more
Dec 1, 2022

BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

Completed
  • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
  • Barretos, SP, Brazil
    Barretos Cancer Hospital
Dec 25, 2022

Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Sep 29, 2022

Breast Cancer Trial in Tampa (Eribulin, Carboplatin)

Completed
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 28, 2022

NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 16, 2023

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Mar 28, 2023

Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Recurrent
  • Debio 0123
  • +2 more
  • Madrid, Spain
  • +3 more
Apr 3, 2023

Efficacy and Safety Trial in Zhejiang (pegylated liposomal doxorubicin, paclitaxel, Carboplatin)

Active, not recruiting
  • Efficacy and Safety
  • pegylated liposomal doxorubicin
  • +2 more
  • Zhejiang, Hangzhou, China
    Women's Hospital School Of Medicine Zhejiang University
Jul 14, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • SonoCloud-9 (SC9)
  • +3 more
  • Chicago, Illinois
  • +7 more
Jun 5, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Odense, Denmark
  • +3 more
Oct 16, 2023

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022